Table 2.
The relationship between the prevalence of ED and complete blood cell-derived inflammatory biomarkers.
| continuous | Quartiles of CBC-derived inflammatory biomarkers levels | P trend | |||||
|---|---|---|---|---|---|---|---|
| OR (95%CI) | P value | Q1 | Q2 | Q3 | Q4 | ||
| NLR | |||||||
| Crude | 1.27(1.18,1.36) | < 0.001 | - | 0.92(0.67,1.25) | 1.23(0.96,1.57) | 2.16(1.70,2.73) | < 0.001 |
| Model 1 | 1.09(1.01,1.19) | 0.028 | - | 0.68(0.49,0.95) | 0.97(0.71,1.24) | 1.17(0.88,1.56) | 0.091 |
| Model 2 | 1.10(1.01,1.20) | 0.018 | - | 0.74(0.52,1.06) | 1.03(0.76,1.41) | 1.25(0.91,1.71) | 0.052 |
| Model 3 | 1.09(1.00,1.19) | 0.021 | - | 0.75(0.50,1.11) | 1.01(0.73,1.39) | 1.25(0.91,1.73) | 0.061 |
| dNLR | |||||||
| Crude | 0.64(0.12,3.42) | 0.6 | - | 0.87(0.69,1.10) | 0.76(0.60,0.94) | 1.05(0.81,1.38) | > 0.9 |
| Model 1 | 1.11(0.12,10.1) | > 0.9 | - | 0.85(0.63,1.14) | 0.70(0.53,0.94) | 1.19(0.84,1.70) | 0.5 |
| Model 2 | 1.26(0.09,16.9) | 0.9 | - | 0.89(0.63,1.24) | 0.75(0.55,1.03) | 1.23(0.82,1.83) | 0.5 |
| Model 3 | 0.92(0.07,12.6) | > 0.9 | - | 0.89(0.61,1.30) | 0.74(0.54,1.02) | 1.19(0.80,1.79) | 0.6 |
| MLR | |||||||
| Crude | 13.8(6.88,27.6) | < 0.001 | - | 1.04(0.71,1.50) | 1.46(1.09,1.94) | 2.32(1.71,3.15) | < 0.001 |
| Model 1 | 2.50(1.04,6.02) | 0.032 | - | 0.80(0.53,1.22) | 0.96(0.70,1.32) | 1.11(0.75,1.64) | 0.4 |
| Model 2 | 2.94(1.15,7.51) | 0.015 | - | 0.89(0.58,1.38) | 1.10(0.77,1.57) | 1.24(0.81,1.91) | 0.2 |
| Model 3 | 2.97(1.18,7.50) | 0.01 | - | 0.88(0.54,1.41) | 1.12(0.76,1.66) | 1.25(0.79,1.97) | 0.2 |
| NMLR | |||||||
| Crude | 1.26(1.18,1.35) | < 0.001 | - | 0.86(0.66,1.12) | 1.17(0.92,1.49) | 2.16(1.70,2.75) | < 0.001 |
| Model 1 | 1.09(1.01,1.18) | 0.014 | - | 0.65(0.49,0.86) | 0.87(0.67,1.15) | 1.15(0.86,1.54) | 0.12 |
| Model 2 | 1.10(1.02,1.19) | 0.007 | - | 0.70(0.53,0.93) | 0.96(0.70,1.31) | 1.23(0.90,1.69) | 0.064 |
| Model 3 | 1.10(1.01,1.11) | 0.006 | - | 0.71(0.52,0.98) | 0.93(0.67,1.28) | 1.25(0.90,1.73) | 0.073 |
| SIRI | |||||||
| Crude | 1.27(1.17,1.39) | < 0.001 | - | 1.07(0.85,1.35) | 1.43(1.08,1.88) | 2.25(1.85,2.74) | < 0.001 |
| Model 1 | 1.15(1.05,1.26) | 0.002 | - | 0.89(0.69,1.14) | 1.05(0.76,1.45) | 1.45(1.09,1.93) | 0.009 |
| Model 2 | 1.11(1.01,1.22) | 0.019 | - | 0.88(0.65,1.19) | 1.04(0.71,1.51) | 1.35(0.98,1.87) | 0.055 |
| Model 3 | 1.11(1.01,1.22) | 0.017 | - | 0.82(0.60,1.13) | 1.02(0.67,1.54) | 1.28(0.91,1.81) | 0.1 |
| SII | |||||||
| Crude | 1.00(1.00,1.00) | < 0.001 | - | 0.99(0.76,1.29) | 1.06(0.81,1.39) | 1.44(1.16,1.80) | 0.003 |
| Model 1 | 1.00(1.00,1.01) | 0.2 | - | 0.92(0.66,1.29) | 1.03(0.74,1.43) | 1.23(0.89,1.70) | 0.14 |
| Model 2 | 1.00(1.00,1.02) | 0.2 | - | 0.99(0.70,1.42) | 1.14(0.81,1.61) | 1.28(0.91,1.80) | 0.1 |
| Model 3 | 1.00(1.00,1.03) | 0.2 | - | 0.98(0.68,1.42) | 1.18(0.79,1.74) | 1.25(0.86,1.82) | 0.13 |
Crude Model: Unadjusted for covariates; Model 1: Adjusted for age and race; Model 2: Adjusted for age, race, marital status, BMI, PIR, education, smoking, alcohol consumption, and physical activity; Model 3: Fully adjusted model including all covariates.